Skip to main content
Fig. 1 | BMC Psychiatry

Fig. 1

From: Altered expression of the CSMD1 gene in the peripheral blood of schizophrenia patients

Fig. 1

Comparison of CSMD1 expression levels in the SCZ, SCZ_12w, and HC groups. Notes: HCs: Healthy controls; SCZ: schizophrenia patients before treatment; SCZ_12w: schizophrenia patients after 12 weeks of treatment. The expression levels of the CSMD1 gene in the PBMCs of the SCZ patients were lower than in the HCs. Mann–Whitney U test, P < 0.05. The expression levels of the CSMD1 gene in the PBMCs of the SCZ_12w patients were higher than in the baseline SCZ patients. Mann–Whitney U test, P < 0.05

Back to article page